This meeting report outlines the objective to develop European Guidance for managing cancer-associated thrombosis in complex clinical scenarios lacking robust evidence.
Answers are grounded in this paper and cite their sources.
European expert consensus now aids complex cancer-associated thrombosis management; leaves open dedicated trials to strengthen evidence.
The EuroG20 meeting on cancer-associated thrombosis (CAT) convened in Bergamo, Italy on 7 April 2016 to discuss a selection of controversial topics in CAT management. This satellite meeting besides ICTHIC in Bergamo has the objective to propose an European Guidance on CAT in various complex situations where evidence-based guidelines are lacking, driven by eminence-based thoughts of 20 experts and key opinion leaders in thrombosis from EU area and 8 experts from the rest of the world.
No takes yet. Share an insight, caveat, or question.
Elalamy et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: